Jonathan Sallet explains the need to move place-based technology innovation policy forward, especially in difficult economic times.
While touting the goals of competitiveness and job creation, the “Pledge to America” ignores innovation and education as systemic prerequisites for sustainable economic growth.
Public policymakers need to grasp converging distinctions among science, technology, invention, and innovation to ensure our economy remains competitive and entrepreneurial.
Maryann Feldman and Lauren Lanahan's look at the efficacy of regional innovation programs in the eastern Midwest regional economy.
Climate disruption caused by global warming driven by human emissions of greenhouse gases by any other name is still Hell and High Water.
The House version of The America COMPETES Re-authorization bill includes a section emphasizing NSF’s Broader Impacts Merit Review Criterion. That’s a good thing.
Embryonic stem cell researcher Jeanne Lorring, Ph.D. updates us on the judicially imposed ban on embryonic stem cell research, and sends a special invitation to the judge responsible.
Arthur Caplan reviews Worst Case Bioethics, and advances the case for a national philosophy of medicine for bioethics.
Why what you think you know about agricultural biotechnology may be wrong.
A ruling barring NIH funds from use in embryonic stem cell research will hurt American research efforts and send cutting-edge biotechnology jobs to Asia.
The misguided human embryonic stem cell research ruling by a U.S. court would discontinue amazing gains made over the past 12 years in regenerative medicine.
On August 24th the Department of Energy Announced that a consortium of 90 organizations anchored at Penn State University will receive $129 million of to support energy efficiency innovation.
A poorly argued decision upends critical embryonic stem cell research funded by the National Institutes of Health.
Scientists conclude that recent glacial calving of a giant ice island off the Greenland ice shelf is a clear symptom of a warming world.
A new test can detect with great accuracy the development of Alzheimer's years before symptoms occur. Jonathan Moreno muses on the ethical and political implications of this new medical milestone.
The FDA's myopic focus on early-stage testing and lack of emphasis on phase four human clinical trials has led to many safety-related drug recalls in recent years, meriting a reexamination of our regulatory system.
Paul Greenberg, author of the new book Four Fish: the Future of the Last Wild Food, discusses humanity's changing relationship with the oceans in this podcast interview and book review.
In their new book Merchants of Doubt, Naomi Oreskes and Erik Conway document how the cast of characters peddling pseudo-science had been stunningly consistent over the years, from secondhand smoke skeptics to “Star Wars” missile defense proponents to modern climate science deniers.
The Food and Drug Administration approves the first clinical trial for embryonic stem cell treatment in patients with recent spinal cord injuries—creating a much needed regulatory pathway.
The massive environmental damage requires a systematic approach to the analysis of public policy priorities and the costs BP must bear over the long term.
The federal government should partner with venture capitalists to help our nation’s innovative small businesses build the equity capital they need to grow and prosper in the United States.
The idea of informed consent has grown up, and it’s time to rethink the reasoning behind the consent system for tissue donation, writes Jonathan Moreno.
Public policy makers need to manage the risks and rewards of this promising new life sciences industry, particularly with an eye on the global context.
Ethics concerns arise about testing company 23andMe’s genetic data-gathering efforts prior to the publication of a key research paper by the company.
A pilot initiative from the federal government could accelerate the great potential of breakthrough innovations arising from academic research.
A new study points to the possibility that retina cells can be derived from embryonic stem cells, but new regulatory procedures need to be in place to oversee the research going forward.
The true measure of a clinical trial’s worth is not whether it provides dying patients access to unproven medications, but rather, whether it produces a bountiful yield of knowledge that empowers future healthcare providers.
Critics of synthetic biology who fear that scientists are overstepping boundaries should have raised their objections in the 19th century.
Pollution in coastal waters around the country has damaged shellfish habitats for decades, but promising restoration programs can preserve the tiny bivalves that are crucial to healthy waters along our shorelines.
The emerging technology is cause for celebration but risks overreaction that could inhibit innovation.
For the networks of scholars who study innovation to fully understand the process, they must examine innovation in a networked world.
Innovation month continues as Jonathan Sallet reminds us that bottom-up regional innovation and economic development strategies are all the more crucial in times of economic recovery. As well, your editors Jonathan D. Moreno and Sean Pool take a look at the changing relationships between science and technology, invention and innovation, and also explore the conspicuous lack of any of these words in the “Pledge to America.” Also don’t forget to have a look at Maryann Feldman and Lauren Lanahan’s new study of a regional manufacturing innovation cluster in the eastern Midwest.
© Center for American Progress
Science Progress is a Project of
